Staphylococcus warneri ISK-1 produces a lantibiotic, nukacin ISK-1. The nukacin ISK-1 gene cluster consists of at least six genes, nukA, -M, -T, -F, -E, and -G, and two open reading frames, ORF1 and ORF7 (designated nukH). Sequence comparisons suggested that NukF, -E, -G, and -H contribute to immunity to nukacin ISK-1. We investigated the immunity levels of recombinant Lactococcus lactis expressing nukFEG and nukH against nukacin ISK-1. The co-expression of nukFEG and nukH resulted in a high degree of immunity. The expression of either nukFEG or nukH conferred partial immunity against nukacin ISK-1. These results suggest that NukH contributes cooperatively to self-protection with Nuk-FEG. The nukacin ISK-1 immunity system might function against another lantibiotic, lacticin 481. Western blot analysis showed that NukH expressed in Staphylococcus carnosus was localized in the membrane. Peptide release/bind assays indicated that the recombinant L. lactis expressing nukH interacted with nukacin ISK-1 and lacticin 481 but not with nisin A. These findings suggest that NukH contributes cooperatively to host immunity as a novel type of lantibiotic-binding immunity protein with NukFEG.
Among the bacteriocins produced by certain grampositive bacteria, the lantibiotics are small (<5 kDa) bacteriocins that contain unusual amino acids such as dehydroalanine, dehydrobutyrine, lanthionine, and 3-methyllanthionine. [1] [2] [3] Based on their structure and functions, they can be classified into type-A (linear type) and type-B (globular type) groups.
2) Based on the size, charge, and sequence of the leader peptides, the type-A group is further divided into two subgroups,
type-A(I) and type-A(II).
Type-A lantibiotics form pores in the cytoplasmic membrane of sensitive cells, which subsequently leads to cell death.
2) Lantibiotic producers possess protection systems against self-produced lantibiotics. The immunity proteins found in the lantibiotic producers are generally classified into two groups, LanFEG and LanI. 2, 4, 5) LanFEG is a membrane protein complex which functions as an ABC transporter system to export the produced lantibiotics from the cell to the outside. 6) LanF is an intracellular ATPase subunit containing ATP-binding domain with Walker motifs A and B. 7, 8) LanE and LanG possess membrane-spanning domains and represent transmembrane subunits. There is a wide diversity in the features of LanI as compared to LanFEG. NisI (245 amino acids) for nisin and SpaI (165 amino acids) for subtilin are synthesized as proteins containing lipoprotein signal sequences and attached to the membrane by a lipid-modified N-terminal cysteine. 9, 10) These lipoproteins provide no cross-immunity and contribute cooperatively to full immunity with the respective LanFEG-related complexes, NisFEG and SpaFG. In contrast, it appears that LanI proteins, unlike NisI and SpaI, contribute to full immunity. PepI (69 amino acids) for Pep5 is associated with the membrane by the hydrophobic N-terminal segment. 11, 12) Interestingly, PepI shows high sequence similarity (74.2%) to EciI (62 amino acids) for epicidin 280. 13) These proteins provide cross-immunity between the producers. LtnI (116 amino acids) for lacticin 3147 is predicted to be localized in the membrane, and possesses the leucinezipper motif that is associated with protein dimerization. 14) Nukacin ISK-1 is a type-A(II) lantibiotic produced by Staphylococcus warneri ISK-1 (JCM 11004). [15] [16] [17] [18] The putative structure of nukacin ISK-1 (MW 2960 Da) y To whom correspondence should be addressed. Fax: +81-92-642-3019; E-mail: sonomoto@agr.kyushu-u.ac.jp Abbreviation: NICE, nisin-controlled expression agreed with that of lacticin 481 (MW 2901 Da) in terms of number of amino acid residues and position of unusual amino acids. 18) They showed similar antimicrobial spectra. 16) Previous studies indicate that the gene cluster of nukacin ISK-1 encoded on plasmid pPI-1 19) consists of at least six genes, its structural gene (nukA), a post-translational modification enzyme (nukM), a processing and secretion ABC transporter gene (nukT), immunity ABC transporter genes (nukFEG), and two ORFs, ORF1 and ORF7 (designated nukH). 18, 20, 21) These ORFs, except for ORF1 and nukH, are commonly found in the biosynthetic gene clusters of lacticin-481 type lantibiotics. 2, 4, 5) The ORF1 product shows similarity in the N-terminal half to the AlgR/AgrA/LytR family proteins. 18, 22) The nukH ORF was found immediately downstream of nukFEG. NukH showed similarity to the ORF4 product (96 amino acids) of Butyrivibrio fibrisolvens OR79 23) and RumH (98 amino acids) of Ruminococcus gnavus E1, 24) which are putative accessory proteins encoded downstream of the gene clusters for immunity complexes to butyrivibriocin OR79A and ruminococcin A respectively (analyzed by GENETYX-WIN, Software Development, Tokyo, Japan). Furthermore, nukH, the ORF4, and rumH products showed very similar hydrophobic profiles, indicating the presence of three membrane-spanning domains, suggesting that they belong to the same protein family, but the molecular functions of these proteins have not been characterized yet. The present study indicates that NukH is located in the cellular membrane and confers a high degree of immunity when expressed with a putative NukFEG protein complex, and that the nukH-expressing L. lactis binds nukacin ISK-1 peptide. We also address the target specificity of this immunity system with other lantibiotics, lacticin 481 and nisin A. In sum, our data provide strong evidence that NukH functions as a novel type of lantibiotic-binding immunity protein.
Materials and Methods
Bacterial strains and plasmids. The bacterial strains and plasmids used in this study are listed in Table 1 . S. warneri ISK-1 (JCM 11004) 15) was cultured in half concentrated MRS medium (Oxoid, Hampshire, United Kingdom) 18) with shaking at 37 C. L. lactis subsp. lactis CNRZ481 25) was cultured in MRS medium without shaking at 30 C. Escherichia coli JM109 26) used as a cloning host and S. carnosus TM300 27) were grown in LB medium 28) at 37 C. L. lactis NZ9000 29) was grown in M17 medium (Merck, Darmstadt, Germany) supplemented with 0.5% glucose (GM17) at 30 C. Plasmid pNZ8048 30) was used for the expression of nukFEGH. Plasmid pTX15 31) was used for the expression of hexahistidine-tagged nukH. For the selection of transformants carrying pNZ8048 and their derivatives, chloramphenicol was used at a concentration of 10 mg/ml. For the selection of transformants carrying pTX15 and its derivative, tetracycline was used at a concentration of 12.5 mg/ml.
Bacterial transformations. Transformation of E. coli JM109 by electroporation was performed according to the protocol recommended for the Gene Pulser apparatus (Bio-Rad, Hercules, CA, U.S.A.). L. lactis NZ9000 and S. carnosus TM300 were transformed according to the methods developed by Holo and Nes 32) and Götz and Schumacher 27) respectively.
Plasmid constructions. Plasmid DNAs of recombinant L. lactis NZ9000 and S. carnosus TM300 were isolated according to the method developed by O'Sullivan and Klaenhammer, 33) except that 0.1 mg/ml of lysostaphin (Seikagaku, Tokyo, Japan) was used for cell lysis of recombinant S. carnosus TM300. PCR was performed using KOD plus DNA polymerase (Toyobo, Osaka, Japan). Primer sequences and restriction sites are shown in Table 2 . Plasmid construction for the expression of the immunity genes nukFEG and nukH was performed in the following manner: Gene fragments of nukFEG, nukFEGH, and nukH were prepared by PCR with sets of appropriate primers, nukF5
0 -nukG3 0 , nukF5 0 -nukH3 0 , and nukH5 0 -nukH3 0 (Table 2) . Each amplified fragment was digested with NcoI and SacI, or PagI and SacI, and cloned into pNZ8048 at the NcoI and SacI sites. Subsequently the plasmids pNZFEG, pNZFEGH, and pNZH were obtained.
For the construction of pTXH, the gene fragment of nukH was prepared by PCR with sets of appropriate primers, ptxnukH5 0 -ptxnukH3 0 ( Table 2 ). The amplified fragment was digested with BamHI and NarI, and cloned into pTX15 at the BamHI and NarI sites. Subsequently the plasmid pTXH was obtained.
These constructed plasmids were confirmed by DNA sequencing. Other standard molecular procedures were followed as described by Sambrook et al.
28)
Purification of nukacin ISK-1, lacticin 481, and nisin A. Purification of nukacin ISK-1 and lacticin 481 was performed in the following manner: After cultivation of S. warneri ISK-1 and L. lactis subsp. lactis CNRZ481 in 2 liters of MRS media for 12 h, the cells were removed by centrifugation at 6;000 Â g for 5 min. The lantibiotics in the media were adsorbed to 40 g of Amberlite XAD-16 resin (Sigma Chemical, St. Louis, MO, U.S.A.) with shaking for 3 h. The resin was washed with water and subsequently with 40% ethanol. The adsorbed lantibiotics were eluted with 200 ml of 70% isopropanol. After the eluates were evaporated, material was dissolved in 200 ml of 20 mM sodium phosphate buffer (pH 5.7) for nukacin ISK-1 or with 20 mM sodium citrate buffer (pH 3.5) for lacticin 481. The solutions were then applied on a cation exchange column, SPSepharose (Sigma Chemical). Nukacin ISK-1 and lacticin 481 were eluted with 0.5 and 0.25 M NaCl respectively, followed by further purification by RP-HPLC using a Resource RPC column (Amersham Pharmacia Biotech, Uppsala, Sweden). The lantibiotics were eluted by a linear gradient of 20-60% acetonitrile in water containing 0.1% trifluoroacetic acid for 30 min. The flow rate was 1 ml/min and the eluates were monitored by absorbance at 220 nm.
For purification of nisin A, crude nisin purchased from Sigma was subjected to the purification step using the SP-Sepharose column described above. Nisin A was eluted with 0.5 M NaCl, followed by further purification by RP-HPLC.
Expression of genes using the NICE system. For the expression of nukFEGH, the nisin-controlled expression (NICE) system was used. This expression system is based on the autoregulatory properties of the antimicrobial peptide nisin produced by L. lactis. Expression using the NICE system was performed according to the protocol. 29, 30) Overnight cultures of recombinant L. lactis were diluted 100-fold in fresh GM17 liquid media. After the cultures reached an OD 600 of 0.8, nisin solution (crude nisin purchased from Sigma dissolved in water adjusted to pH 3.0 with HCl) was added at a concentration of 10 ng/ml for induction of the recombinant genes. After the induction of immunity genes by addition of nisin A at 30 C under static conditions, the cultures were used for further experiments.
Immunity assay of recombinant L. lactis. Induction of the immunity genes in recombinant L. lactis strains by addition of nisin A was performed overnight. After the respective purified lantibiotics (50 mg/ml) were serially diluted with water, paper disks containing 50 ml of serially diluted lantibiotics were put on plates of Lactobacilli Agar AOAC (Difco Laboratories, Detroit, MI) supplemented with nisin and chloramphenicol at concentrations of 10 ng/ml and 10 mg/ml respectively, and seeded with the transformants (100-fold dilution). After incubation at 30 C for 18 h, the radii (R) of the inhibitory zones were measured and the radius (R 0 ) of the paper disk was subtracted. Halo was defined as r 2 (r ¼ R À R 0 ). When needed, MIC (the minimum inhibitory concentration) was determined from the highest serial dilution showing a clear visible zone according to the method described previously. Northern blot hybridization. The transcriptional levels of nukFEGH in the transformants were estimated by dot blot hybridization with specific probes for either nukF or nukH according to the method described previously. 35) The probes for dot blot hybridization were amplified by PCR with sets of appropriate primers pronukF5 0 -pronukF3 0 and pronukH3 0 -pronukH5 0 (Table 2) .
Localization analysis of NukH-His 6 in S. carnosus TM300. The recombinant S. carnosus TM300 strain was cultured in LB broth supplemented with 0.5% xylose for 16 h. The cells were harvested, washed with 100 mM potassium phosphate buffer (pH 8.0), and treated with 0.1 mg/ml of lysostaphin for 30 min. The lysed cells were disrupted using a French press (20,000 psi), and intact cells were removed by centrifugation at 6;000 Â g for 20 min. Soluble and insoluble proteins were separated by ultracentrifugation at 125;000 Â g for 2 h. The supernatant (cytoplasmic fraction) and the viscous pellet (membrane fraction) were separated by Tricine SDS-PAGE and subjected to Western blot analysis using antihistidine-tag antibody to detect NukH fused to hexahistidine-tag. Western blot analysis was essentially performed using the PentaÁHis HRP Conjugate Kit (Qiagen GmbH, Hilden, Germany) according to the manufacturer's protocol.
Quantitation of cell-bound and free nukacin ISK-1. Quantitative peptide release/bind assays were performed according to the method described by Stein et al. 36) After induction of the recombinant L. lactis harboring plasmid pNZ8048 and its derivatives containing nukFEGH, nukFEG, and nukH for 3 h by addition of nisin A, the cells were harvested and washed twice with 50 mM Tris-HCl buffer (pH 8.0). The cell concentration was adjusted to an OD 600 of 10 with an incubation buffer that contained 50 mM sodium phosphate buffer (pH 7.0) and 1% glucose. When the function of NukH was assayed, 1 M NaCl was added to the incubation buffer. One milliliter of the cell suspensions was incubated with nukacin ISK-1, lacticin 481, or nisin A at a concentration of either 5 or 25 mg/ml with shaking (120 rpm) for 30 min at 30 C. After incubation, the cells were centrifuged at 20;000 Â g for 5 min and the supernatants were saved. The harvested cell pellets were washed with the incubation buffer and gently mixed with 1 ml of 20% acetonitrile in water containing 0.1% trifluoroacetic acid with shaking (120 rpm) for 5 min at 30 C. The cells were removed by centrifugation at 20;000 Â g for 5 min and the supernatants were saved. Quantification of lantibiotics in the respective supernatants was performed by RP-HPLC using a Resource RPC column under the same condition as in the case of purification. The integrated peak areas corresponding to the respective lantibiotics allowed the quantification of lantibiotics.
Results

Effects of expression and inactivation of nukFEGH in L. lactis on immunity to nukacin ISK-1
In order to investigate the functions of the proteins encoded by nukFEG and nukH, these genes were cloned into pNZ8048 and introduced into L. lactis NZ9000. Subsequently, the immunity levels of the recombinant L. lactis against nukacin ISK-1 were examined (Fig. 1A) . L. lactis transformed with pNZFEGH grew in the presence of the highest dose of nukacin ISK-1 tested (MIC > 50 mg/ml) ( ). The lack of nukH from the pNZFEGH transformant greatly decreased its immunity (MIC, 6.25 mg/ml) ( ). Compared to L. lactis Induction of immunity genes in recombinant L. lactis with vector plasmid pNZ8048 without immunity genes ( ) and expressing nukFEGH ( ), nukFEG ( ), and nukH ( ) by addition of nisin A was done overnight. The immunity levels of recombinant L. lactis were then investigated by agar diffusion assay using nukacin ISK-1, lacticin 481, or nisin A at appropriate concentrations. Paper disks containing serially diluted lantibiotics were put on plates of Lactobacilli Agar AOAC supplemented with nisin and chloramphenicol at concentrations of 10 ng/ml and 10 mg/ml respectively, and seeded with the transformants (100-fold dilution). Straight lines between the concentrations of the respective lantibiotics applied and the square of the radii of the halos after incubation at 30 C for 18 h were obtained. This assay was performed in duplicate at least, and the average was plotted. transformed with pNZ8048 (MIC, 1.56 mg/ml) ( ), L. lactis transformed with only nukH exhibited slight immunity (MIC, 3.13 mg/ml) ( ). Quantitative analysis using dot blot hybridization showed that the difference in immunity levels was not due to a difference in the transcriptional level of immunity genes (data not shown).
Investigation of immunity levels of L. lactis expressing nukFEGH against lacticin 481 and nisin A
We examined the immunity levels of recombinant L. lactis expressing nukacin ISK-1 immunity genes against the other lantibiotics, lacticin 481 and nisin A (Fig. 1B and C) . Lacticin 481 and nisin A are type-A(II) and type-A(I) lantibiotics, respectively. The pNZFEG and pNZH transformants conferred similar levels of immunity (MIC, 3.13 mg/ml) ( and ), whereas the pNZFEGH transformants showed full immunity to lacticin 481 as well as nukacin ISK-1 (MIC > 50 mg/ ml) ( ). In this case, the pNZ8048 transformant showed the highest sensitivity to lacticin 481 (MIC, 1.56 mg/ml) ( ). This result suggests that the immunity system for nukacin ISK-1 also confers immunity to lacticin 481. In contrast, the nukacin ISK-1 immunity genes did not provide increased protection against nisin A.
Localization of NukH in S. carnosus TM300
Hydropathy profile analysis suggested that NukH possesses three transmembrane domains. 20) To test whether NukH is localized in the cell membrane, we analyzed the localization of NukH by Western blot analysis using recombinant S. carnosus TM300. The strain was transformed with the plasmid designated pTXH containing the nukH gene fused to a sequence coding hexahistidine residues downstream of the xylose inducible promoter P xyl . Hexahistidine-tagged NukH (11.5 kDa) was detected in the membrane fraction (Fig. 2) . The upper band of NukH-His 6 was also observed in the membrane fraction of the host strain by Western blot analysis, while the band corresponding to 11.5 kDa did not appear (data not shown).
Functional analysis of NukFEGH by quantitative peptide release/bind assay
We characterized the function of NukFEGH by quantitative peptide release/bind assay using 5 mg/ml of nukacin ISK-1 (Fig. 3) . A 1.4-fold increased amount of nukacin ISK-1 in the supernatant of the pNZFEG transformant was observed as compared to the pNZ8048 transformant. This result suggests that a putative NukFEG complex extruded nukacin ISK-1 from the cell membrane. The amount of nukacin ISK-1 in the supernatant of pNZFEGH transformant was four times lower than in the case of pNZFEG transformant. This result suggests that NukH expression contributes to cellbinding of nukacin ISK-1 even in the presence of NukFEG.
Investigation of the lantibiotic-binding function of NukH by quantitative peptide release/bind assay
To investigate the lantibiotic-binding function of NukH, we used quantitative peptide release/bind assays with nukacin ISK-1, lacticin 481, and nisin A at a concentration of 5 mg/ml. A larger amount of applied nukacin ISK-1 was cell-associated in the case of pNZH transformant (Fig. 3) . This result suggests that the nukHexpressing strain bound nukacin ISK-1. However, almost all the applied lacticin 481 and nisin A at 5 mg/mlassay solution were observed to be cell-associated even in the case of pNZ8048 transformant (data not shown). This might be due to the fact that lacticin 481 and nisin A show higher binding affinity to the cytoplasmic membrane of the host cell, L. lactis NZ9000, than nukacin ISK-1. To investigate the target specificity of NukH against lacticin 481 and nisin A, we did assays using 25 mg/ml of lantibiotics in the presence of 1 M NaCl (Fig. 4) . Addition of NaCl to the assay solution appears to decrease the amount of cell-associated S. carnosus TM300. Lanes 1, 2, and 3 were loaded with 60 mg of proteins from the induced recombinant S. carnosus TM300 crude extract, cytoplasm, and membrane fractions respectively. Western blot was performed using anti-histidine-tag antibody to detect hexahistidine-tagged NukH (NukH-His 6 ). The corresponding molecular masses of peptide markers are indicated on the left. lantibiotics.
36) The nukH-expressing strain bound lacticin 481 as in the case of nukacin ISK-1 even in the presence of NaCl, whereas it did not bind nisin A. This finding suggests that NukH is specific for lacticin 481 as well as nukacin ISK-1.
Discussion
It appears that LanI can be classified into two groups. Some LanI proteins contribute cooperatively to complete immunity with LanFEG, such as NisI for nisin 10) and SpaI for subtilin.
9) The other LanI proteins, such as PepI for Pep5, 11, 12) EciI for epicidin 280, 13) and LtnI for lacticin 3147, 14) can fully function alone without LanFEG complex. NukH contributes to a high degree of immunity to lantibiotics only in combination with NukFEG. Indeed, NukH appears to be similar to NisI and SpaI, but the features of NukH relative to NisI and SpaI differ in the following respects: (i) size, (ii) membrane-associated state, and (iii) target specificity against lantibiotics. First, the sizes of NukH, NisI and SpaI, are different (92, 245, and 165 amino acids respectively) (analyzed by GENETYX-WIN). Localization analysis showed that NukH was located at the cytoplasm membrane, and hydropathy analysis suggested the presence of three transmembrane domains of NukH. In contrast, NisI and SpaI have typical lipoprotein signal sequences and are attached to the outer surface of the membrane. 9, 10) These findings indicate that the membrane-associated state of NukH might be different from those of NisI and SpaI. Additionally, there is a difference in the target specificities of NukH and NisI against lantibiotics. Quantitative peptide release/bind assays suggested that the recombinant L. lactis expressing nukH interacted with nukacin ISK-1 and lacticin 481 but not with nisin A. This indicates that the similarity of binding epitopes plays an important role in the function of NukH as an immunity protein for various types of lantibiotics. Stein et al. 36) reported that heterologously expressed NisI from E. coli interacted with nisin but not subtilin, although the structure of subtilin is quite similar to that of nisin. These findings suggest that NukH shows a wide range of substrate specificity compared to NisI. In conclusion, we propose that NukH is a novel type of lantibiotic-binding immunity protein.
It appears that the ORF4 product of B. fibrisolvens OR79 23) and RumH of R. gnavus E1, 24) along with NukH, might belong to the same family. NukH showed similarity (51% and 57% respectively) to the ORF4 product (96 amino acids) and RumH (98 amino acids). All three products showed very similar hydropathy profiles indicating three transmembrane regions (as analyzed by GENETYX-WIN), and are encoded downstream of the gene clusters for immunity complexes, lanFEG. Although the functions of the ORF4 product and RumH have not been identified, these findings suggest that they might have the same function as NukH, and that they probably contribute the self-protection against the respective lantibiotics in combination with the respective LanFEG complexes.
The immunity assay showed that the presence of two immunity systems conferred by NukFEG and NukH provided a much higher degree of immunity than the sum of both together (Fig. 1A and B) . Immunity in response to either system alone was small. This finding suggests that two immunity systems, NukFEG and NukH, confer immunity cooperatively rather than independently. Expression of nukFEG resulted in a higher degree of immunity than did expression of nukH. This finding suggests that a putative NukFEG complex plays a major role in the self-protection system, and that NukH might function as an accessory protein for NukFEG.
Comparing the results of the peptide release/bind assay and the immunity assay (Figs. 1A and 3 ), it appears that the release/binding level is not consistent with the immunity level. This discrepancy was also After induction of recombinant L. lactis with vector plasmid pNZ8048 and expression of nukH by the addition of nisin A, the cell suspensions (OD 600 ¼ 10) were incubated with nukacin ISK-1, lacticin 481, or nisin A at a concentration of 25 mg/ml in the presence of 1 M NaCl under the conditions described in Fig. 3 . The amounts of the respective lantibiotics remaining in the supernatants (open bars) and the amounts of the cellassociated ones (filled bars) were quantified by RP-HPLC. The average is expressed with error bars representing standard deviations. observed in the study on the functions of NisFEGI against nisin. 36) Recently, the effects of nisin immunity genes in a heterologous host on protection against the type-A(I) lantibiotics nisin and subtilin were investigated. 36) In this study, we demonstrated the effects of nukacin ISK-1 immunity genes in a heterologous host on the protection to both type-A(I) and (II) lantibiotics, nukacin ISK-1, lacticin 481, and nisin A. The nukacin ISK-1 immunity proteins NukF, -E, and -G also showed high relatedness (79%, 56%, and 60% respectively) to the lacticin 481 immunity proteins LctF, -E, and -G, consistently with the fact that NukFEG conferred immunity to lacticin 481. Recombinant L. lactis expressing the nukacin ISK-1 immunity genes showed similar immunity against nukacin ISK-1 and lacticin 481. In contrast, the nukacin ISK-1 immunity genes did not enhance immunity to nisin A. This finding suggests that the immunity system for nukacin ISK-1 cannot function well against nisin A, which might be due to the great differences in the structure of lantibiotics and the immunity system.
Studies of the mode of action of a nukacin ISK-1-type lantibiotic, streptococcin FF22, have revealed that the lantibiotic associates with the cytoplasmic membrane and subsequently forms transmembrane pores. 37) With respect to the contribution of NukH to immunity levels and interactions of nukH-expressing strains on nukacin ISK-1 and lacticin 481 (Figs. 1A, B, 4A , and B), NukH might bind the lantibiotics and subsequently prevent them from inserting into the cytoplasmic membrane and/or prevent high densities of the lantibiotics for survival around nukH-expressing strains.
In summary, it is suggested that NukH functions as a novel type of immunity protein for lantibiotics and greatly contributes to self-protection against lantibiotics in cooperation with NukFEG. These results ought to be supported by an experiment on direct interaction between NukH and lantibiotics; however, it seems that it is, at present at least, difficult to perform this experiment because of quite low expression of NukH in any host strains, and of the difficulty of preparing the transmembrane protein (data not shown). On the other hand, for characterization of the molecular function of NukH, we have characterized the membrane topology and functional domains of NukH in L. lactis NZ9000. 38) Our investigations on NukH are currently aimed at these further experiments to understand the evolution, diversity, and molecular function of immunity proteins for lantibiotics.
